Credit Suisse analyst A.J. Rice raised the firm’s price target on Encompass Health to $73 from $62 and keeps an Outperform rating on the shares following quarterly results. The firm notes Encompass saw higher contract labor rates in Q4 over Q3 but incurred lower utilization.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EHC:
- Encompass Health price target raised to $73 from $68 at UBS
- Encompass Health sees FY23 adjusted EPS $2.87-$3.16, consensus $3.25
- Encompass Health reports results for fourth quarter 2022 and issues full-year 2023 guidance
- Encompass Health reports Q4 adjusted EPS 88c, consensus 83c
- Encompass Health added to Analyst Current Favorites list at Raymond James